Overview of Spasmocure
What is Spasmocure? Overview
| Property | Description |
|---|---|
| Active Ingredient | Drotaverine hydrochloride |
| Form | Tablet (Oral) and Solution for injection (Parenteral) |
| Pharmacological Class | Myotropic Antispasmodic Agent |
| General Purpose | Relief of visceral spasm and associated pain |
| Origin | Synthetic compound |
What Type of Medicine is Spasmocure? (Identity and Classification)
Spasmocure is a medicinal product defined by its active component, Drotaverine hydrochloride, and is classified as a Myotropic Antispasmodic Agent. This classification places it among drugs specifically designed to relax involuntary muscle contractions. Drotaverine is a synthetic compound, manufactured chemically, and is chemically related to the older compound papaverine. It exhibits greater selectivity toward smooth muscle tissue. This antispasmodic agent exerts its primary action directly upon the smooth muscle fibers found in internal organs, such as the gastrointestinal and genitourinary tracts, ensuring a focused, direct effect on the spastic tissue.
Composition and Forms of Drotaverine (Ingredients and Presentation)
The core composition of Spasmocure is a single-ingredient product, containing only the active ingredient Drotaverine hydrochloride. The product is made available in two primary dosage form(s) to suit different clinical needs and route of administration. The most common preparation is the Oral formulation (Tablet), suitable for general use, while a sterile Parenteral formulation (Solution for injection) is provided for administration via the parenteral route when a rapid therapeutic effect is necessary. This dual presentation—offering both tablet and injectable forms—is a characteristic feature of Drotaverine preparations in markets where it is predominantly used.
What is the General Purpose of an Antispasmodic Agent? (Mechanism and Benefit)
The general purpose of Spasmocure is to provide effective relief from pain and discomfort caused by involuntary muscular spasms, such as the sudden, sharp pain experienced during an abdominal cramp. This medicine achieves its effect by relaxing the constricted, overactive smooth muscles, a condition clinically known as visceral spasm. By directly acting on the muscle cell—a myotropic action—Drotaverine functions as a selective Phosphodiesterase-4 (PDE4) inhibitor. This mechanism alleviates the underlying smooth muscle hypermotility and resolves the associated spastic pain within the organs of the digestive and urogenital systems, without involving central nervous system modulation.
Regulatory References
